Telormedix SA
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Telormedix SA
Asia On The Move: CFDA Deputy Commissioner Moves To Sichuan
April always brings with it a flurry of personnel changes. China FDA deputy commissioner Yin Li is heading to a leadership position in Sichuan province, Takeda COO Christophe Weber has become CEO and Otsuka has a new chairman, while personnel changes also took place at Aslan and CROs WuXiPRA and George Clinical.
Positive PhII bladder cancer data fuel Telormedix's search for partner
Swiss biopharmaceutical company Telormedix has completed a successful Phase II study of Vesimune (TMX-101) in patients with bladder cancer, and is now hoping to find a partner for the drug by the third quarter of this year.
Recent Financings of Private Companies (02/2012)
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical device sectors.
Scrip Intelligence presents its latest Roundtable on Managing Biotechs
Scrip Intelligence has released its latest Roundtable discussion, Capital Efficiency: Managing Biotechs in Straitened Times.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice